Acadian Asset Management LLC Karyopharm Therapeutics Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 368,511 shares of KPTI stock, worth $257,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
368,511
Previous 194,168
89.79%
Holding current value
$257,957
Previous $167,000
82.04%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KPTI
# of Institutions
98Shares Held
57.6MCall Options Held
258KPut Options Held
81.2K-
Vanguard Group Inc Valley Forge, PA7.65MShares$5.36 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY5.55MShares$3.88 Million0.36% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$3.57 Million0.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.32MShares$3.02 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.92 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $55.9M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...